Health Canada issues recall for mislabelled THC level

Health Canada announced today that on March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot...

Eric Costen, Health Canada

Health Canada announced today that on March 8, 2017, Aphria, a licensed producer of cannabis for medical purposes located in Ontario, began a voluntary recall of one lot of dried marijuana under a Type III recall. One lot (652-4883) of cannabis was mislabelled as containing 22.3% THC instead of 21.1% THC.

A Type III recall refers to "a situation in which the use of, or exposure to a product, is not likely to cause any adverse health consequences."

Health Canada says they have not received any adverse reaction reports for products sold by Aphria. Health Canada recommends that any individual affected by the recall immediately stop using the recalled product and to contact Aphria at the following number: 1-844-427-4742.

Aphria released this statement to Lift today: "On March 8, 2017, Aphria identified 20 patient orders in which the label incorrectly identified the actual THC content. As a result, Aphria issued a voluntary recall and all but one order has been returned. The variance is not likely to cause any adverse health consequences. Aphria has identified the source of the labelling issue and has implemented measures to prevent reoccurrence."

Official link here.

Health Canada lists their three recall types as such

  • Type I: a situation in which there is a reasonable probability that the use of, or exposure to, a product will cause serious adverse health consequences or death,
  • Type II: a situation in which the use of, or exposure to, a product may cause temporary adverse health consequences or where the probability of serious adverse health consequences is remote, or
  • Type III: a situation in which the use of, or exposure to, a product is not likely to cause any adverse health consequences.

Type III recalls do not generally warrant a public recall, but a Type I or II recall does. In the past, Health Canada has issued public recalls for other medical cannabis, but has not detailed if it was a Type I, II or III.

Earlier this year, Health Canada Media Relations Officer André Gagnon said the agency has already begun to list all cannabis-related recalls, regardless of concern for public health.they would be announcing cannabis recalls of all kinds, regardless of risk to public health.

“As a part of its commitment to openness and transparency, and in an effort to ensure Canadians are well informed of recalls under the Access to Cannabis for Medical Purposes Regulations, Health Canada has begun posting all cannabis for medical purposes recalls, regardless of public health risks, to the department’s online recall database. In addition, we will continue to publish annual and quarterly compliance and enforcement reports with information about medical cannabis recalls and other compliance and enforcement actions undertaken by the Department.”

This is the ninth recall of medical cannabis in Canada since 2014, and the second for inaccurate THC level. More on recalls here.

In this article


Join the Conversation